Channel Therapeutics announces 10-for-1 reverse split ahead of NYSE American uplisting
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 27 2025
0mins
Source: SeekingAlpha
Reverse Stock Split Announcement: Channel Therapeutics will execute a 10-for-1 reverse stock split on July 1, 2025, to comply with NYSE American listing requirements ahead of a merger and capital raise.
Company Name Change: Following the reverse split, the company will be renamed Pelthos Therapeutics and will start trading under this new name on July 2, 2025.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
